Genetesis Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$17.5M
- Investors
-
25
Genetesis General Information
Description
Developer of a biomagnetic imaging tool designed to improve patients' health and outcomes of life. The company's system is non-invasive and requires no patient exposure to radiation or exercise during the procedure and is intended to measure and display the magnetic signals produced by the electric currents in the heart, enabling clinicians to measure the magnetic field naturally generated by the heart during action potential driven myocardial contraction and relaxation.
Contact Information
Website
www.genetesis.comCorporate Office
- 5412 Courseview Drive
- Suite 150
- Mason, OH 45040
- United States
Corporate Office
- 5412 Courseview Drive
- Suite 150
- Mason, OH 45040
- United States
Genetesis Timeline
Genetesis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series C) | 17-Jun-2022 | $17.5M | Completed | Generating Revenue | ||
| 11. Later Stage VC (Series B) | 14-Jun-2022 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | 01-May-2022 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 18-Oct-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 07-May-2020 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 01-May-2020 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jun-2017 | Completed | Generating Revenue | |||
| 5. Grant | 10-May-2017 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2016 | $20K | $410K | Completed | Generating Revenue | |
| 3. Angel (individual) | 02-Jun-2015 | $150K | $410K | Completed | Generating Revenue |
Genetesis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 Class B | 69,853 | $0.000010 | $4.52 | $4.52 | 1x | $4.52 | 0.82% | |
| Series A-1 Class A | 435,885 | $0.000010 | $3.13 | $3.13 | 1x | $3.13 | 5.09% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Genetesis Comparisons
Industry
Financing
Details
Genetesis Competitors (1)
One of Genetesis’s competitors is HeartFlow, a Venture Capital-Backed company based in Mountain View, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| HeartFlow | Venture Capital-Backed | Mountain View, CA |
Genetesis Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Genetesis Patents
Genetesis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230329944-A1 | Shielded chamber for diagnostic evaluation of medical conditions | Pending | 04-Mar-2022 | ||
| CA-3209292-A1 | Biomagnetic field sensor systems and methods for diagnostic evaluation of cardiac conditions | Pending | 22-Feb-2021 | ||
| US-20230181078-A1 | Systems and devices for detecting coronary artery disease using magnetic field maps | Pending | 27-May-2020 | ||
| EP-4157079-A1 | Systems and devices for detecting coronary artery disease using magnetic field maps | Pending | 27-May-2020 | ||
| EP-4157079-A4 | Systems and devices for detecting coronary artery disease using magnetic field maps | Pending | 27-May-2020 | A61B5/243 |
Genetesis Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Genetesis Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cercano Management | PE/Buyout | Minority | ||
| JobsOhio Growth Capital | Venture Capital | Minority | ||
| LOUD Capital | Venture Capital | Minority | ||
| Mithril Capital Management | Venture Capital | Minority | ||
| 10X Capital | Venture Capital | Minority |
Genetesis FAQs
-
When was Genetesis founded?
Genetesis was founded in 2013.
-
Where is Genetesis headquartered?
Genetesis is headquartered in Mason, OH.
-
What is the size of Genetesis?
Genetesis has 37 total employees.
-
What industry is Genetesis in?
Genetesis’s primary industry is Diagnostic Equipment.
-
Is Genetesis a private or public company?
Genetesis is a Private company.
-
What is the current valuation of Genetesis?
The current valuation of Genetesis is .
-
What is Genetesis’s current revenue?
The current revenue for Genetesis is .
-
How much funding has Genetesis raised over time?
Genetesis has raised $32.2M.
-
Who are Genetesis’s investors?
Cercano Management, JobsOhio Growth Capital, LOUD Capital, Mithril Capital Management, and 10X Capital are 5 of 25 investors who have invested in Genetesis.
-
Who are Genetesis’s competitors?
HeartFlow is a competitor of Genetesis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
